gadolinium dtpa has been researched along with dysprosium in 21 studies
| Studies (gadolinium dtpa) | Trials (gadolinium dtpa) | Recent Studies (post-2010) (gadolinium dtpa) | Studies (dysprosium) | Trials (dysprosium) | Recent Studies (post-2010) (dysprosium) |
|---|---|---|---|---|---|
| 12,654 | 664 | 4,051 | 577 | 3 | 207 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 19 (90.48) | 18.2507 |
| 2000's | 2 (9.52) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barker, PB; Bryan, RN; Conturo, TE; Mathews, VP; Monsein, LH | 1 |
| Kiihne, S; Weisskoff, RM | 1 |
| Bauer, WR; Schulten, K | 1 |
| Higgins, CB; Saeed, M; Wendland, MF | 3 |
| Asgari, H; Kucharczyk, J; Mintorovitch, J; Moseley, M; Rocklage, S; Vexler, Z; Watson, A | 1 |
| Asgari, HS; Derugin, N; Kucharczyk, J; Mintorovitch, J; Moseley, ME; Rocklage, S; Vexler, Z | 1 |
| Higgins, CB; Saeed, M; Wendland, M | 1 |
| Nilsson, S | 1 |
| Ericsson, A; Hemmingsson, A; Nilsson, S; Oksendal, A; Waldenström, A; Wikström, G; Wikström, M | 2 |
| Runge, VM; Wells, JW | 1 |
| Bach-Gansmo, T; Ericsson, A; Hemmingsson, A; Niklasson, F | 1 |
| Delos, M; Demeure, R; Goudemant, JF; Jamart, J; Maldague, B; Oksendal, A; Pringot, J; Thiran, JP; Van Beers, BE | 1 |
| Derugin, N; Geschwind, JF; Higgins, CB; Lauerma, K; Saeed, M; Wendland, MF | 1 |
| Colet, JM; Fahlvik, AK; Fossheim, SL; Kellar, KE; Klaveness, J; Mansson, S; Rongved, P | 1 |
| Fossheim, SL; Kellar, KE; Spiller, M | 1 |
| Higgins, CB; Lund, G; Saeed, M; Wendland, MF | 1 |
| Bach-Gansmo, T; Buzelin, MF; Dupas, B; Karam, G; Meflah, K; Vasse, N | 1 |
| Martin, AJ; Roberts, TP; Saeed, M; Weber, OM | 1 |
2 review(s) available for gadolinium dtpa and dysprosium
| Article | Year |
|---|---|
Update: safety, new applications, new MR agents.
Topics: Animals; Brain; Brain Diseases; Contrast Media; Dysprosium; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Organometallic Compounds; Pentetic Acid | 1995 |
Contrast-enhanced MRI for quantification of myocardial viability.
Topics: Animals; Contrast Media; Dysprosium; Edetic Acid; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Manganese; Myocardial Ischemia; Myocardial Stunning; Organometallic Compounds; Pentetic Acid; Pyridoxal Phosphate | 1999 |
19 other study(ies) available for gadolinium dtpa and dysprosium
| Article | Year |
|---|---|
MR imaging of cerebral perfusion by phase-angle reconstruction of bolus paramagnetic-induced frequency shifts.
Topics: Animals; Brain; Brain Ischemia; Capillaries; Cerebrovascular Circulation; Contrast Media; Dysprosium; Electron Spin Resonance Spectroscopy; Gadolinium; Gadolinium DTPA; Image Enhancement; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Microcirculation; Models, Biological; Models, Chemical; Models, Structural; Organometallic Compounds; Papio; Pentetic Acid; Putamen | 1992 |
MRI susceptometry: image-based measurement of absolute susceptibility of MR contrast agents and human blood.
Topics: Contrast Media; Dextrans; Dysprosium; Erythrocytes; Ferrosoferric Oxide; Gadolinium; Gadolinium DTPA; Humans; Image Processing, Computer-Assisted; In Vitro Techniques; Iron; Magnetic Resonance Imaging; Magnetite Nanoparticles; Organometallic Compounds; Oxides; Pentetic Acid | 1992 |
Theory of contrast agents in magnetic resonance imaging: coupling of spin relaxation and transport.
Topics: Contrast Media; Dysprosium; Ferrosoferric Oxide; Gadolinium; Gadolinium DTPA; Humans; Iron; Kupffer Cells; Magnetic Resonance Imaging; Models, Biological; Models, Theoretical; Organometallic Compounds; Oxides; Pentetic Acid | 1992 |
Strategies for differential enhancement of myocardial ischemia using echoplanar imaging.
Topics: Animals; Contrast Media; Coronary Disease; Dysprosium; Female; Gadolinium; Gadolinium DTPA; Image Enhancement; Magnetic Resonance Imaging; Myocardium; Organometallic Compounds; Pentetic Acid; Rats; Rats, Inbred Strains | 1991 |
Characterization of reperfused myocardial infarctions with T1-enhancing and magnetic susceptibility-enhancing contrast media.
Topics: Animals; Contrast Media; Diagnosis, Differential; Drug Evaluation, Preclinical; Dysprosium; Gadolinium; Gadolinium DTPA; Magnetic Resonance Imaging; Myocardial Infarction; Myocardial Reperfusion Injury; Organometallic Compounds; Pentetic Acid; Rats; Rats, Inbred Strains | 1991 |
Magnetic resonance imaging of brain perfusion using the nonionic contrast agents Dy-DTPA-BMA and Gd-DTPA-BMA.
Topics: Animals; Brain; Cats; Contrast Media; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Dysprosium; Gadolinium; Gadolinium DTPA; Magnetic Resonance Imaging; Organometallic Compounds; Pentetic Acid; Time Factors | 1991 |
Comparison of Gd- and Dy-chelates for T2 contrast-enhanced imaging.
Topics: Animals; Brain; Brain Ischemia; Cats; Contrast Media; Dysprosium; Gadolinium; Gadolinium DTPA; Magnetic Resonance Imaging; Organometallic Compounds; Pentetic Acid | 1991 |
Contrast enhancement for the myocardium.
Topics: Animals; Contrast Media; Coronary Disease; Dysprosium; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Myocardium; Organometallic Compounds; Pentetic Acid | 1991 |
Magnetic resonance contrast media for myocardial imaging.
Topics: Animals; Contrast Media; Coronary Disease; Dysprosium; Gadolinium; Gadolinium DTPA; Magnetic Resonance Imaging; Organometallic Compounds; Pentetic Acid; Pyridoxal Phosphate; Rats | 1990 |
MR imaging of contrast-enhanced porcine myocardial infarction. Assessment of reperfusion and tissue viability.
Topics: Analysis of Variance; Animals; Contrast Media; Diagnosis, Differential; Dysprosium; Evaluation Studies as Topic; Female; Gadolinium; Gadolinium DTPA; Magnetic Resonance Imaging; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion; Myocardium; Organometallic Compounds; Pentetic Acid; Swine; Time Factors; Tissue Survival | 1995 |
MR imaging of double-contrast enhanced porcine myocardial infarction. Correlation with microdialysis.
Topics: Analysis of Variance; Animals; Contrast Media; Disease Models, Animal; Drug Interactions; Dysprosium; Female; Gadolinium; Gadolinium DTPA; Magnetic Resonance Imaging; Male; Microdialysis; Myocardial Infarction; Myocardium; Organometallic Compounds; Pentetic Acid; Swine; Time Factors | 1995 |
Combination of gadolinium and dysprosium chelates as a cellular integrity marker in MR imaging.
Topics: Cell Membrane; Contrast Media; Dysprosium; Erythrocytes; Gadolinium; Gadolinium DTPA; Hematocrit; Humans; Image Enhancement; In Vitro Techniques; Magnetic Resonance Imaging; Organometallic Compounds; Pentetic Acid | 1995 |
Double-contrast MR imaging of reperfused porcine myocardial infarction. An experimental study using Gd-DTAA and Dy-DTPA-BMA.
Topics: Animals; Contrast Media; Disease Models, Animal; Drug Evaluation, Preclinical; Dysprosium; Female; Gadolinium; Gadolinium DTPA; Magnetic Resonance Angiography; Male; Myocardial Infarction; Myocardial Reperfusion; Myocardium; Organometallic Compounds; Pentetic Acid; Swine | 1996 |
Detection of reperfused ischemia of the rat intestine: value of magnetic resonance imaging with small-molecular-weight dysprosium and gadolinium chelates.
Topics: Animals; Contrast Media; Dysprosium; Gadolinium; Gadolinium DTPA; Image Enhancement; Injections, Intravenous; Intestines; Ischemia; Magnetic Resonance Imaging; Male; Molecular Weight; Organometallic Compounds; Pentetic Acid; Rats; Rats, Wistar | 1997 |
AUR Memorial Award. Identification of myocardial cell death in reperfused myocardial injury using dual mechanisms of contrast-enhanced magnetic resonance imaging.
Topics: Animals; Awards and Prizes; Cell Death; Contrast Media; Drug Evaluation, Preclinical; Dysprosium; Gadolinium DTPA; Magnetic Resonance Imaging; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Organometallic Compounds; Pentetic Acid; Rats; Rats, Sprague-Dawley | 1994 |
Investigation of lanthanide-based starch particles as a model system for liver contrast agents.
Topics: Animals; Contrast Media; Dysprosium; Gadolinium DTPA; Liver; Magnetic Resonance Imaging; Male; Metals, Rare Earth; Organometallic Compounds; Particle Size; Pentetic Acid; Rats; Rats, Wistar; Spectrophotometry, Atomic; Tissue Distribution | 1999 |
NMRD investigation of DyDTPA- and GdDTPA-labeled starch particles. Selection of a suitable suspension medium and influence of the starch matrix on relaxivity.
Topics: Contrast Media; Dysprosium; Gadolinium DTPA; Humans; Organometallic Compounds; Pentetic Acid; Polyethylene Glycols; Starch | 1999 |
Contrast-enhanced MR imaging of experimental acute tubular necrosis.
Topics: Animals; Contrast Media; Diagnosis, Differential; Drug Combinations; Dysprosium; Gadolinium DTPA; Injections, Intravenous; Kidney Medulla; Kidney Tubular Necrosis, Acute; Kidney Tubules; Magnetic Resonance Imaging; Male; Organometallic Compounds; Pentetic Acid; Rats; Rats, Inbred BN | 2001 |
Steady-state imaging for visualization of endovascular interventions.
Topics: Animals; Aorta; Contrast Media; Dogs; Dysprosium; Fluoroscopy; Gadolinium DTPA; Image Processing, Computer-Assisted; Magnetic Resonance Angiography; Phantoms, Imaging | 2003 |